Skip to main content
Erschienen in: Annals of Surgical Oncology 2/2021

07.07.2020 | Breast Oncology

Lowering Re-excision Rates After Breast-Conserving Surgery: Unraveling the Intersection Between Surgeon Case Volumes and Techniques

verfasst von: Christopher Baliski, MD, FRCSC, Lauren Hughes, BSc, Brendan Bakos, MSc

Erschienen in: Annals of Surgical Oncology | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

The re-excision rates after breast-conserving surgery (BCS) are significantly varied, with surgeon case volume as one influential factor. Surgeons with higher case volumes have been shown to have lower reoperation rates. This study attempted to determine whether this may be attributable to excessive breast tissue removal during initial BCS.

Methods

A retrospective study analyzed referrals to the authors’ cancer center during 3 years. Patients undergoing initial BCS for ductal carcinoma in situ or T1–T3 breast cancers were included. Patient age, tumor factors, surgeon case volume, and the calculated resection ratio (CRR) were analyzed. The total resection volume was divided by the optimal resection volume to produce the CRR, which reflected the magnitude of excess tissue resected during initial BCS. Comparison of the mean CRR between surgeon case-volume categories was performed with a repeated measures analysis of variance. A multivariate regression model assessed the effects of the CRR and surgeon case volume on re-excision rates.

Results

Larger tumor size, lobular histology, and lower CRR were associated with increased re-excision rates. The CRR was similar for each surgeon case-volume group. Surgeon case volume was not independently associated with re-excision rates, but surgeons with very high case volumes had lower odds of re-excision than surgeons with intermediate case volumes (odds ratio 0.44; 95% confidence interval 0.21–0.91).

Conclusions

When control was used for the CRR, apparent differences in re-excision rates between surgeon case-volume groups were observed, suggesting that surgeons with higher case volumes may be more accurate when performing BCS.
Literatur
1.
Zurück zum Zitat Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology–American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol. 2014;21:704–16.CrossRef Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology–American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol. 2014;21:704–16.CrossRef
2.
Zurück zum Zitat Morrow M, Van Zee KJ, Solin LJ, et al. Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ. Ann Surg Oncol. 2016;23:3801–10.CrossRef Morrow M, Van Zee KJ, Solin LJ, et al. Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ. Ann Surg Oncol. 2016;23:3801–10.CrossRef
3.
Zurück zum Zitat Haloua M, Volders J, Krekel N, et al. Intraoperative ultrasound guidance in breast-conserving surgery improves cosmetic outcomes and patient satisfaction: results of a multicenter randomized controlled trial (COBALT). Ann Surg Oncol. 2016;23:30–7.CrossRef Haloua M, Volders J, Krekel N, et al. Intraoperative ultrasound guidance in breast-conserving surgery improves cosmetic outcomes and patient satisfaction: results of a multicenter randomized controlled trial (COBALT). Ann Surg Oncol. 2016;23:30–7.CrossRef
4.
Zurück zum Zitat Dahlbäck C, Manjer J, Rehn M, Ringberg A. Determinants for patient satisfaction regarding aesthetic outcome and skin sensitivity after breast-conserving surgery. World J Surg Oncol. 2016;14:303–13.CrossRef Dahlbäck C, Manjer J, Rehn M, Ringberg A. Determinants for patient satisfaction regarding aesthetic outcome and skin sensitivity after breast-conserving surgery. World J Surg Oncol. 2016;14:303–13.CrossRef
5.
Zurück zum Zitat Hau E, Browne L, Capp A, et al. The impact of breast cosmetic and functional outcomes on quality of life: long-term results from the St. George and Wollongong randomized breast boost trial. Breast Cancer Res Treat. 2013;139:115–23. Hau E, Browne L, Capp A, et al. The impact of breast cosmetic and functional outcomes on quality of life: long-term results from the St. George and Wollongong randomized breast boost trial. Breast Cancer Res Treat. 2013;139:115–23.
6.
Zurück zum Zitat Hill-Kayser C, Chacko D, Hwang WT, Vapiwala N, Solin, L. Long-term clinical and cosmetic outcomes after breast conservation treatment for women with early-stage breast carcinoma according to the type of breast boost. Int J Radiat Oncol Biol Phys. 2011;79:1048–54.CrossRef Hill-Kayser C, Chacko D, Hwang WT, Vapiwala N, Solin, L. Long-term clinical and cosmetic outcomes after breast conservation treatment for women with early-stage breast carcinoma according to the type of breast boost. Int J Radiat Oncol Biol Phys. 2011;79:1048–54.CrossRef
7.
Zurück zum Zitat Jay M, Creelman B, Baliski C. Patient-reported outcomes associated with surgical intervention for breast cancer. Am J Surg. 2020;219:816-822. Jay M, Creelman B, Baliski C. Patient-reported outcomes associated with surgical intervention for breast cancer. Am J Surg. 2020;219:816-822.
8.
Zurück zum Zitat Kelemen P, Pukancsik D, Újhelyi M, et al. Comparison of clinicopathologic, cosmetic, and quality-of-life outcomes in 700 oncoplastic and conventional breast-conserving surgery cases: a single-centre retrospective study. Eur J Surg Oncol. 2019;45:118–24.CrossRef Kelemen P, Pukancsik D, Újhelyi M, et al. Comparison of clinicopathologic, cosmetic, and quality-of-life outcomes in 700 oncoplastic and conventional breast-conserving surgery cases: a single-centre retrospective study. Eur J Surg Oncol. 2019;45:118–24.CrossRef
9.
Zurück zum Zitat Vrouwe SQ, Somogyi RB, Snell L, McMillan C, Vesprini D, Lipa JE. Patient-reported outcomes following breast conservation therapy and barriers to referral for partial breast reconstruction. Plast Reconstr Surg. 2018;141:1–9.CrossRef Vrouwe SQ, Somogyi RB, Snell L, McMillan C, Vesprini D, Lipa JE. Patient-reported outcomes following breast conservation therapy and barriers to referral for partial breast reconstruction. Plast Reconstr Surg. 2018;141:1–9.CrossRef
10.
Zurück zum Zitat Heil J, Breitkreuz K, Golatta M, et al. Do reexcisions impair aesthetic outcome in breast conservation surgery? Exploratory analysis of a prospective cohort study. Ann Surg Oncol. 2012;19:541–7.CrossRef Heil J, Breitkreuz K, Golatta M, et al. Do reexcisions impair aesthetic outcome in breast conservation surgery? Exploratory analysis of a prospective cohort study. Ann Surg Oncol. 2012;19:541–7.CrossRef
11.
Zurück zum Zitat Krekel N, Zonderhuis B, Muller S, et al. Excessive resections in breast‐conserving surgery: a retrospective multicentre study. Breast J. 2011;17:602–9.CrossRef Krekel N, Zonderhuis B, Muller S, et al. Excessive resections in breast‐conserving surgery: a retrospective multicentre study. Breast J. 2011;17:602–9.CrossRef
14.
Zurück zum Zitat Esbona K, Li Z, Wilke LG. Intraoperative imprint cytology and frozen section pathology for margin assessment in breast conservation surgery: a systematic review. Ann Surg Oncol. 2012;19:3236–45.CrossRef Esbona K, Li Z, Wilke LG. Intraoperative imprint cytology and frozen section pathology for margin assessment in breast conservation surgery: a systematic review. Ann Surg Oncol. 2012;19:3236–45.CrossRef
16.
Zurück zum Zitat de Camargo Cancela M, Comber H, Sharp L. Hospital and surgeon caseload are associated with risk of re-operation following breast-conserving surgery. Breast Cancer Res Treat. 2013;140:535–44.CrossRef de Camargo Cancela M, Comber H, Sharp L. Hospital and surgeon caseload are associated with risk of re-operation following breast-conserving surgery. Breast Cancer Res Treat. 2013;140:535–44.CrossRef
17.
Zurück zum Zitat Jeevan R, Cromwell DA, Trivella M, et al. Reoperation rates after breast-conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics. BMJ. 2012;345:18–26.CrossRef Jeevan R, Cromwell DA, Trivella M, et al. Reoperation rates after breast-conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics. BMJ. 2012;345:18–26.CrossRef
18.
Zurück zum Zitat Spilsbury K, Semmens JB, Saunders CM, Holman CDJ. Long‐term survival outcomes following breast cancer surgery in Western Australia. ANZ J Surg. 2005;75:625–30.CrossRef Spilsbury K, Semmens JB, Saunders CM, Holman CDJ. Long‐term survival outcomes following breast cancer surgery in Western Australia. ANZ J Surg. 2005;75:625–30.CrossRef
20.
Zurück zum Zitat McCahill LE, Single RM, Aiello Bowles EJ, et al. Variability in reexcision following breast conservation surgery. JAMA. 2012;307:467–75.CrossRef McCahill LE, Single RM, Aiello Bowles EJ, et al. Variability in reexcision following breast conservation surgery. JAMA. 2012;307:467–75.CrossRef
21.
Zurück zum Zitat Hughes L, Hamm J, McGahan C, Baliski C. Surgeon volume, patient age, and tumor-related factors influence the need for re-excision after breast-conserving surgery. Ann Surg Oncol. 2016;23:656–64.CrossRef Hughes L, Hamm J, McGahan C, Baliski C. Surgeon volume, patient age, and tumor-related factors influence the need for re-excision after breast-conserving surgery. Ann Surg Oncol. 2016;23:656–64.CrossRef
22.
Zurück zum Zitat Vos EL, Jager A, Verhoef C, Voogd AC, Koppert LB. Overall survival in patients with a re-excision following breast-conserving surgery compared to those without in a large population-based cohort. Eur J Cancer. 2015;51:282–91.CrossRef Vos EL, Jager A, Verhoef C, Voogd AC, Koppert LB. Overall survival in patients with a re-excision following breast-conserving surgery compared to those without in a large population-based cohort. Eur J Cancer. 2015;51:282–91.CrossRef
23.
Zurück zum Zitat Dahlbäck C, Ullmark JH, Rehn M, Ringberg A, Manjer J. Aesthetic results after breast-conserving therapy is associated with quality of life several years after treatment: Swedish women evaluated with BCCT.core and BREAST-Q. Breast Cancer Res Treat. 2017;164:679–87. Dahlbäck C, Ullmark JH, Rehn M, Ringberg A, Manjer J. Aesthetic results after breast-conserving therapy is associated with quality of life several years after treatment: Swedish women evaluated with BCCT.core and BREAST-Q. Breast Cancer Res Treat. 2017;164:679–87.
24.
Zurück zum Zitat Lagendijk M, Egdom LSE, Veen FEE, et al. Patient-reported outcome measures may add value in breast cancer surgery. Ann Surg Oncol. 2018;25:3563–71.CrossRef Lagendijk M, Egdom LSE, Veen FEE, et al. Patient-reported outcome measures may add value in breast cancer surgery. Ann Surg Oncol. 2018;25:3563–71.CrossRef
25.
Zurück zum Zitat Santos G, Urban C, Edelweiss M, et al. Long-term comparison of aesthetical outcomes after oncoplastic surgery and lumpectomy in breast cancer patients. Ann Surg Oncol. 2015;22:2500–8.CrossRef Santos G, Urban C, Edelweiss M, et al. Long-term comparison of aesthetical outcomes after oncoplastic surgery and lumpectomy in breast cancer patients. Ann Surg Oncol. 2015;22:2500–8.CrossRef
26.
Zurück zum Zitat O’Connell RL, DiMicco R, Khabra K, et al. Initial experience of the BREAST-Q breast-conserving therapy module. Breast Cancer Res Treat. 2016;160:79–89.CrossRef O’Connell RL, DiMicco R, Khabra K, et al. Initial experience of the BREAST-Q breast-conserving therapy module. Breast Cancer Res Treat. 2016;160:79–89.CrossRef
27.
Zurück zum Zitat Atisha DM, Rushing CN, Samsa GP, et al. A national snapshot of satisfaction with breast cancer procedures. Ann Surg Oncol. 2015;22:361–9.CrossRef Atisha DM, Rushing CN, Samsa GP, et al. A national snapshot of satisfaction with breast cancer procedures. Ann Surg Oncol. 2015;22:361–9.CrossRef
28.
Zurück zum Zitat Volders JH, Negenborn VL, Haloua MH, et al. Breast‐specific factors determine cosmetic outcome and patient satisfaction after breast‐conserving therapy: results from the randomized COBALT study. J Surg Oncol. 2018;117:1001–8.CrossRef Volders JH, Negenborn VL, Haloua MH, et al. Breast‐specific factors determine cosmetic outcome and patient satisfaction after breast‐conserving therapy: results from the randomized COBALT study. J Surg Oncol. 2018;117:1001–8.CrossRef
29.
Zurück zum Zitat Landercasper J, Attai D, Atisha D, et al. Toolbox to reduce lumpectomy reoperations and improve cosmetic outcome in breast cancer patients: the American Society of Breast Surgeons consensus conference. Ann Surg Oncol. 2015;22:3174–83.CrossRef Landercasper J, Attai D, Atisha D, et al. Toolbox to reduce lumpectomy reoperations and improve cosmetic outcome in breast cancer patients: the American Society of Breast Surgeons consensus conference. Ann Surg Oncol. 2015;22:3174–83.CrossRef
30.
Zurück zum Zitat Valero MG, Mallory MA, Losk K, et al. Surgeon variability and factors predicting for reoperation following breast-conserving surgery. Ann Surg Oncol. 2018;25:2573–8.CrossRef Valero MG, Mallory MA, Losk K, et al. Surgeon variability and factors predicting for reoperation following breast-conserving surgery. Ann Surg Oncol. 2018;25:2573–8.CrossRef
31.
Zurück zum Zitat Monaghan A, Chapinal N, Hughes L, Baliski C. Impact of SSO-ASTRO margin guidelines on reoperation rates following breast-conserving surgery. Am J Surg. 2019;217:862–7.CrossRef Monaghan A, Chapinal N, Hughes L, Baliski C. Impact of SSO-ASTRO margin guidelines on reoperation rates following breast-conserving surgery. Am J Surg. 2019;217:862–7.CrossRef
Metadaten
Titel
Lowering Re-excision Rates After Breast-Conserving Surgery: Unraveling the Intersection Between Surgeon Case Volumes and Techniques
verfasst von
Christopher Baliski, MD, FRCSC
Lauren Hughes, BSc
Brendan Bakos, MSc
Publikationsdatum
07.07.2020
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 2/2021
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-08731-z

Weitere Artikel der Ausgabe 2/2021

Annals of Surgical Oncology 2/2021 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.